BIVDA Press Releases

13May

Member Press Release - New England Biolabs to acquire Fluorogenics Limited

IPSWICH, MA (May 10th, 2021) — New England Biolabs, Inc. (NEB®), a leading supplier of life science reagents, today announces that it has entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB.

 

With the point-of-care market becoming more focused on the development of robust, accurate and cost-effective diagnostic tests for use outside of traditional hospital and laboratory settings, there is a growing need for reagents that can withstand ambient shipping and storage. Lyophilization is the preferred solution and is a well-established technology across a number of industries, making it desirable from a regulatory and feasibility perspective. NEB currently supplies research use only reagents for further development and validation by its customers in diagnostic assays, and is looking to increase its ability to offer lyophilized reagents.

 

Read the full Press Release: https://international.neb.com/about-neb/news-and-press-releases/new-england-biolabs-to-acquire-fluorogenics-limited

Related

BIVDA Response to Cancer Research UK Report on Pathology Services

Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology se...

Read More >

All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences.

Read More >

BIVDA Comments on membership of DIT Life Sciences TAG

FOR IMMEDIATE RELEASE BIVDA Joins key DIT Trade Advisory Group on Life Sciences Internatio...

Read More >

BIVDA Comment on Chancellor's Finance Statement

Please find attached and below a press statement from BIVDA Chief Executive Doris-Ann Williams, comm...

Read More >

Member Press Release - New England Biolabs® Introduces ARTIC Products for SARS-CoV-2 Sequencing

New England Biolabs® Introduces ARTIC Products for SARS-CoV-2 Sequencing New kits impr...

Read More >

BIVDA responds to the final report of the Accelerated Access Review

Doris-Ann Williams MBE, Chief Executive of BIVDA, has responded to the publication of the final repo...

Read More >